Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is JSP Pharmaceutical Manufacturing (Thailand) PCL Interest Coverage?
JSP Pharmaceutical Manufacturing (Thailand) PCLBKK:JSP 80 Interest Coverage is 2.44 as of Mar. 2026, which is 49% below its 10-year median of 4.83. GuruFocus rates BKK:JSP with a GF Score™ of 80/100 and a GF Value™ of ฿3.16 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,515 Consumer Packaged Goods companies, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks worse than 53.73% on this metric.
BKK:JSP'
s Interest Coverage Range Over the Past 10 Years
Min: 3.02 Med: 4.83 Max: 7.88
Current: 7.31
BKK:JSP's Interest Coverage is ranked worse than 53.73% of 1515
companies
in the Consumer Packaged Goods industry
Industry Median: 8.63
vs BKK:JSP: 7.31
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
JSP Pharmaceutical Manufacturing (Thailand) PCL Interest Coverage Related Terms
JSP Pharmaceutical Manufacturing (Thailand) PCL Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JSP Pharmaceutical Manufacturing (Thailand) PCL Interest Coverage vs Consumer Packaged Goods Industry
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a Interest Coverage of 2.44 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. This is 49% below median its historical median of 4.83. Over the past decade, JSP Pharmaceutical Manufacturing (Thailand) PCL's Interest Coverage has ranged from 3.02 to 7.88. According to the industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #814 out of 1515 companies in the Consumer Packaged Goods industry, placing it in the top 53.7%.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's Interest Coverage too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current Interest Coverage of 2.44 is 49% below median its 10-year median of 4.83. Over the past 10 years, this metric has ranged from a low of 3.02 to a high of 7.88. The Consumer Packaged Goods industry median Interest Coverage is 8.63. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 2.44 is 71.7% below this industry median. Based on the distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #814 out of 1515 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's Interest Coverage compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #814 out of 1515 companies for Interest Coverage. This places JSP Pharmaceutical Manufacturing (Thailand) PCL in the lower half of its industry. The industry median Interest Coverage is 8.63. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 2.44 is 71.7% below this benchmark. Historically, JSP Pharmaceutical Manufacturing (Thailand) PCL's own Interest Coverage has ranged from 3.02 to 7.88 over the past decade. While the company's 10-year median is 4.83 vs. the industry median of 8.63, JSP Pharmaceutical Manufacturing (Thailand) PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.63, based on 1,515 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Interest Coverage of 2.44 is 71.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Interest Coverage is 2.44, which is 49% below median its own 10-year median of 4.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.16, compared to a current price of ฿1.78 — trading 43.7% below its estimated fair value. The current Interest Coverage is 2.44, which is 49% below median its 10-year median of 4.83 and 71.7% below the Consumer Packaged Goods industry median of 8.63. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current Interest Coverage is 2.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued.
The current stock price of ฿1.78 is trading 43.7% below its estimated GF Value™ of ฿3.16.
GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.
Key valuation signals for BKK:JSP:
Interest Coverage: 2.44 (49% below median its 10-year median of 4.83)
GF Value™: ฿3.16 vs. price of ฿1.78 (43.7% below fair value)
Industry Position: 71.7% below the Consumer Packaged Goods median (#814 of 1515)
No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
80GF Score
Get the complete analysis for BKK:JSP
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:JSP has been successfully added to your 
